Market Overview:
The global vaccines delivery market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for vaccines, and technological advancements in the field of vaccine delivery. The global vaccines delivery market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into biological vector-based vaccines, chemical carrier-based vaccines, and other types such as liposomes and nanoparticles. Biological vector-based vaccines are further subsegmented into viral vectors and nonviral vectors. Chemical carrier-based vaccines are further subsegmented into polymeric carriers and liposomes/nanoparticles. On the basis of application, the market is segmented into hospitals & clinics (including ambulatory care settings), research centers & universities (including contract research organizations), government agencies (such as ministries of health), biopharmaceutical companies (manufacturers or developers of vaccine products)and others including point-of-care settings).
Product Definition:
A vaccine delivery system is a medical device used to administer vaccines. The most common type of vaccine delivery system is the syringe.
Biological Vector:
Biological vectors are living organisms which are used to carry a gene or genes from one place to another. The most common way of doing this is by using bacteria, but there are also other ways like using viruses and even chemical methods.
Biological vectors have been around for thousands of years; the first vaccine was created over 2,000 years ago by the Chinese government against smallpox.
Chemical Carrier:
The chemical carrier is used in vaccines delivery to enable the vaccine to cross the blood-brain barrier and enter into the central nervous system. The chemical carriers are generally classified as organic anion transporters (OAT), peptide/protein transporters, and neutral amino acids.
Application Insights:
Based on the application, the market is segmented into hospital, clinic and research center. The hospital segment dominated the global vaccine delivery market in 2017 due to increasing government funding for immunization programs and rising awareness about immunization schedules. According to WHO, an estimated 925 million children under 5 years of age are not fully vaccinated worldwide. In addition, growing investments by companies such as Merck & Co., Inc., Pfizer Inc., sanofi pasteur LLC among others in R&D pertaining to new vaccines is expected to drive growth over the forecast period.
The Clinic segment is anticipated register a significant CAGR during the forecast period owing to high demand for preventive healthcare services resulting in increased usage of vaccines across clinics and hospitals worldwide. Furthermore, growing investments by companies such as Merck & Co., Inc.; Pfizer; sanofi pasteur LLC among others pertaining new product development will further boost growth over the forecast period (2017 To 2030).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical manufacturers and advanced healthcare infrastructure are some factors driving the regional growth. Moreover, increasing R&D activities for development of new vaccines is also expected to drive demand over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising government initiatives for immunization programs and growing awareness about various vaccination campaigns in this region. Furthermore, improving healthcare facilities in developing countries such as India and China are further expected to boost revenue generation from this region during the forecast period (2018-2030). In addition, growing investment by foreign players for expansion into Asian markets will also contribute toward regional growth rate over next eight years (2018-2030).
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global vaccines delivery market. According to the World Health Organization (WHO), every year, around 2-3 million people die due to infections, and many more fall ill. This is mainly because a large number of people do not have access to essential health services and vaccines. Thus, there is a huge demand for effective vaccines delivery systems that can help in delivering these life-saving drugs to patients in remote areas.
- Technological advancements: The technological advancements in the field of vaccine delivery are another key factor driving the growth of this market. With continuous innovations taking place, new and improved vaccine delivery technologies are being developed that can help improve patient outcomes while reducing costs associated with treatment procedures. For instance, recent advances in needle-free injection technology are helping make vaccinations more comfortable and less painful for patients while also reducing wastage rates associated with traditional needle injections methodsologies .
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccines Delivery Market Research Report
By Type
Biological Vector, Chemical Carrier, Others
By Application
Hospital, Clinic, Research Center
By Companies
Becton Dickinson and Company (BD), BioCSL, Novavax Inc., Vaxart Inc., Vaxxas, Echo Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Vaccines Delivery Market Report Segments:
The global Vaccines Delivery market is segmented on the basis of:
Types
Biological Vector, Chemical Carrier, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson and Company (BD)
- BioCSL
- Novavax Inc.
- Vaxart Inc.
- Vaxxas
- Echo Therapeutics
Highlights of The Vaccines Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biological Vector
- Chemical Carrier
- Others
- By Application:
- Hospital
- Clinic
- Research Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccines Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaccines delivery is the process of administering vaccines to people. Vaccines can be delivered in many ways, including through injections, inhalers, or tablets.
Some of the major players in the vaccines delivery market are Becton Dickinson and Company (BD), BioCSL, Novavax Inc., Vaxart Inc., Vaxxas, Echo Therapeutics.
The vaccines delivery market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaccines Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vaccines Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vaccines Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vaccines Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vaccines Delivery Market Size & Forecast, 2020-2028
4.5.1 Vaccines Delivery Market Size and Y-o-Y Growth
4.5.2 Vaccines Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biological Vector
5.2.2 Chemical Carrier
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Research Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaccines Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaccines Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biological Vector
9.6.2 Chemical Carrier
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Research Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biological Vector
10.6.2 Chemical Carrier
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Research Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biological Vector
11.6.2 Chemical Carrier
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Research Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biological Vector
12.6.2 Chemical Carrier
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Research Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biological Vector
13.6.2 Chemical Carrier
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Research Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaccines Delivery Market: Competitive Dashboard
14.2 Global Vaccines Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson and Company (BD)
14.3.2 BioCSL
14.3.3 Novavax Inc.
14.3.4 Vaxart Inc.
14.3.5 Vaxxas
14.3.6 Echo Therapeutics
